Fig. 4
From: Altered endotoxin responsiveness in healthy children with Down syndrome
Neutrophil and monocyte CD11b expression in response to LPS and melatonin in children with DS versus controls: Samples were treated with Lipopolysaccharide (LPS), Melatonin (Mel), Lipopolysaccharide and melatonin (LPS + Mel) and Lipopolysaccharide (LPS) versus Lipopolysaccharide and melatonin (LPS/ LPS + Mel) and expressed as fold changes in mean channel fluorescence (MFI). p* < 0.05. a Neutrophil CD11b (DS n = 23; Controls n = 16); b Total monocyte CD11b (DS n = 19; Controls n = 21); c Classical monocyte CD11b (DS n = 19; Controls n = 21); d Intermediate CD11b (DS n = 18; Controls n = 20); e Non-classical monocyte CD11b (DS n = 19; Controls n = 21)